Crossmark

TET2 deficiency increases the competitive advantage of hematopoietic stem and progenitor cells through upregulation of thrombopoietin receptor signaling

Crossref DOI link: https://doi.org/10.1038/s41467-025-57614-y

Published Online: 2025-03-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yang, Yitong

Cathelin, Severine

Liu, Alex C. H.

Subedi, Amit

Maher, Abdula https://orcid.org/0009-0009-6535-6888
Hosseini, Mohsen

Manikoth Ayyathan, Dhanoop

Vanner, Robert https://orcid.org/0000-0003-1169-1778
Chan, Steven M. https://orcid.org/0000-0002-4354-0731
Funding

Funding for this research was provided by:

Leukemia and Lymphoma Society of Canada

University of Toronto

Gouvernement du Canada | Canadian Institutes of Health Research
License Information

Text and Data Mining valid from 2025-03-10

Version of Record valid from 2025-03-10
More Information

Article History

Received: 22 March 2024

Accepted: 27 February 2025

First Online: 10 March 2025

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below